Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |